HUANG Cheng, LIN Gen, GOU Lan-ying. Clinical Modes of EGFR Tyrosine Kinase Inhibitor Failure and Subsequent Management in Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 37-40. DOI: 10.3969/j.issn.1671-5144.2013.01.005
Citation:
|
HUANG Cheng, LIN Gen, GOU Lan-ying. Clinical Modes of EGFR Tyrosine Kinase Inhibitor Failure and Subsequent Management in Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 37-40. DOI: 10.3969/j.issn.1671-5144.2013.01.005
|
HUANG Cheng, LIN Gen, GOU Lan-ying. Clinical Modes of EGFR Tyrosine Kinase Inhibitor Failure and Subsequent Management in Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 37-40. DOI: 10.3969/j.issn.1671-5144.2013.01.005
Citation:
|
HUANG Cheng, LIN Gen, GOU Lan-ying. Clinical Modes of EGFR Tyrosine Kinase Inhibitor Failure and Subsequent Management in Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 37-40. DOI: 10.3969/j.issn.1671-5144.2013.01.005
|